Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Multiparametric liquid biopsy analysis in metastatic prostate cancer.

Hodara E, Morrison G, Cunha A, Zainfeld D, Xu T, Xu Y, Dempsey PW, Pagano PC, Bischoff F, Khurana A, Koo S, Ting M, Cotter PD, Moore MW, Gunn S, Usher J, Rabizadeh S, Danenberg P, Danenberg K, Carpten J, Dorff T, Quinn D, Goldkorn A.

JCI Insight. 2019 Mar 7;4(5). pii: 125529. doi: 10.1172/jci.insight.125529. eCollection 2019 Mar 7.

2.

Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue.

Gunn SR, Govender S, Sims CL, Khurana A, Koo S, Scoggin J, Moore MW, Cotter PD.

J Mol Diagn. 2018 May;20(3):279-288. doi: 10.1016/j.jmoldx.2018.01.004. Epub 2018 Feb 19.

PMID:
29471114
4.

The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases.

O'Malley DP, Zuckerberg L, Smith LB, Barry TS, Gunn S, Tam W, Orazi A, Kim YS, Weiss LM.

Ann Diagn Pathol. 2014 Feb;18(1):18-20. doi: 10.1016/j.anndiagpath.2013.10.003. Epub 2013 Oct 29.

PMID:
24321462
5.

Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer.

Gunn S, Reveles X, Weldon K, Barrera A, Ishaque M, Taylor D, McCaskill C, Kim J, Shah R, Mohammed M, Barry T, Kaiser B, Patnaik A, Tolcher A.

J Ovarian Res. 2013 Jan 4;6(1):2. doi: 10.1186/1757-2215-6-2.

6.

Array-based karyotyping in plasma cell neoplasia after plasma cell enrichment increases detection of genomic aberrations.

Zehentner BK, Hartmann L, Johnson KR, Stephenson CF, Chapman DB, de Baca ME, Wells DA, Loken MR, Tirtorahardjo B, Gunn SR, Lim L.

Am J Clin Pathol. 2012 Oct;138(4):579-89.

PMID:
23010713
7.

The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.

Shimizu T, Tolcher AW, Papadopoulos KP, Beeram M, Rasco DW, Smith LS, Gunn S, Smetzer L, Mays TA, Kaiser B, Wick MJ, Alvarez C, Cavazos A, Mangold GL, Patnaik A.

Clin Cancer Res. 2012 Apr 15;18(8):2316-25. doi: 10.1158/1078-0432.CCR-11-2381. Epub 2012 Jan 19.

8.

A novel familial 11p15.4 microduplication associated with intellectual disability, dysmorphic features, and obesity with involvement of the ZNF214 gene.

Sofos E, Pescosolido MF, Quintos JB, Abuelo D, Gunn S, Hovanes K, Morrow EM, Shur N.

Am J Med Genet A. 2012 Jan;158A(1):50-8. doi: 10.1002/ajmg.a.34290. Epub 2011 Nov 3.

PMID:
22052655
9.

Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.

Dawson AJ, Bal S, McTavish B, Tomiuk M, Schroedter I, Ahsanuddin AN, Seftel MD, Vallente R, Mai S, Cotter PD, Hovanes K, Gorre M, Gunn SR.

Cancer Genet. 2011 Jun;204(6):344-7. doi: 10.1016/j.cancergen.2011.05.005.

PMID:
21763633
10.

The role of new genetic technology in investigating autism and developmental delay.

Shur N, Gunn S, Feit L, Oh AK, Yatchmink Y, Abuelo D.

Med Health R I. 2011 May;94(5):131, 134-7. Review. No abstract available.

PMID:
21710921
11.

Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.

Gunn S, Yeh IT, Lytvak I, Tirtorahardjo B, Dzidic N, Zadeh S, Kim J, McCaskill C, Lim L, Gorre M, Mohammed M.

BMC Cancer. 2010 Jul 28;10:396. doi: 10.1186/1471-2407-10-396.

12.

Microdeletion of chromosome 15q24.3-25.2 and orofacial clefting.

Sing B, Song D, DeSandre G, Govindaswami B, Rosenthal S, Gunn S, Wallerstein R.

Cleft Palate Craniofac J. 2011 Sep;48(5):596-600. doi: 10.1597/09-077. Epub 2010 Jun 2.

PMID:
20518684
13.
14.

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event.

Yeh IT, Martin MA, Robetorye RS, Bolla AR, McCaskill C, Shah RK, Gorre ME, Mohammed MS, Gunn SR.

Mod Pathol. 2009 Sep;22(9):1169-75. doi: 10.1038/modpathol.2009.78. Epub 2009 May 15.

15.

Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene.

Gunn SR, Bolla AR, Barron LL, Gorre ME, Mohammed MS, Bahler DW, Mellink CH, van Oers MH, Keating MJ, Ferrajoli A, Coombes KR, Abruzzo LV, Robetorye RS.

Leuk Res. 2009 Sep;33(9):1276-81. doi: 10.1016/j.leukres.2008.10.010. Epub 2008 Nov 21.

PMID:
19027161
16.

Molecular and clinical characterization of a recurrent cryptic unbalanced t(4q;18q) resulting in an 18q deletion and 4q duplication.

Horbinski C, Carter EM, Heard PL, Sathanoori M, Hu J, Vockley J, Gunn S, Hale DE, Surti U, Cody JD.

Am J Med Genet A. 2008 Nov 15;146A(22):2898-904. doi: 10.1002/ajmg.a.32557.

18.

Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.

Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, Preobrazhensky SN, Higgins RA, Bolla AR, Ismail SH, de Jong D, Eldering E, van Oers MH, Mellink CH, Keating MJ, Schlette EJ, Abruzzo LV, Robetorye RS.

J Mol Diagn. 2008 Sep;10(5):442-51. doi: 10.2353/jmoldx.2008.080033. Epub 2008 Aug 7.

19.

The HemeScan test for genomic prognostic marker assessment in chronic lymphocytic leukemia.

Gunn SR, Mohammed MS, Mellink CH, Abruzzo LV, Robetorye RS.

Expert Opin Med Diagn. 2008 Jun;2(6):731-40. doi: 10.1517/17530059.2.6.731.

PMID:
23495782
20.

Comparative genomic hybridization arrays in clinical pathology: progress and challenges.

Gunn SR, Robetorye RS, Mohammed MS.

Mol Diagn Ther. 2007;11(2):73-7. Review.

PMID:
17397242

Supplemental Content

Loading ...
Support Center